Literature DB >> 12778013

Treatment of skull base tumors.

Sujit S Prabhu1, Franco Demonte.   

Abstract

The rich multidisciplinary environment in which skull base surgery has developed has allowed for significant progress in the field and has improved patient outcomes. More precise and detailed anatomic dissection in the laboratories has provided surgeons with the benefit of undertaking the serious technical challenges encountered in the skull base. Significant work has been done and continues to be developed in the field of adjuvant treatments including radiotherapy, chemotherapy, and hormonal therapy. Using biologic end points and specific genetic targets in the tumors may further expand our management options in the future.

Entities:  

Mesh:

Year:  2003        PMID: 12778013     DOI: 10.1097/00001622-200305000-00005

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  4 in total

Review 1.  Pathologic aspects of skull base tumors.

Authors:  Andrzej Marszałek; Łukasz Szylberg; Sławomir Wiśniewski
Journal:  Rep Pract Oncol Radiother       Date:  2016-04-03

2.  Brain meningioma invading and destructing the skull bone: replacement of the missing bone in vivo.

Authors:  Tomaz Velnar; Rado Pregelj; Clara Limbaeck-Stokin
Journal:  Radiol Oncol       Date:  2011-11-16       Impact factor: 2.991

3.  Stereotactic ablative radiosurgery for locally advanced or recurrent skull base malignancies with prior external beam radiation therapy.

Authors:  Karen M Xu; Kimmen Quan; David A Clump; Robert L Ferris; Dwight E Heron
Journal:  Front Oncol       Date:  2015-03-17       Impact factor: 6.244

4.  Treatment of malignant tumors of the skull base with multi-session radiosurgery.

Authors:  Nicholas D Coppa; Daniel M S Raper; Ying Zhang; Brian T Collins; K William Harter; Gregory J Gagnon; Sean P Collins; Walter C Jean
Journal:  J Hematol Oncol       Date:  2009-04-02       Impact factor: 17.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.